Docking Studies for Multi-Target Drugs

• Published in: Current drug targets Vol. 18; no. 5; p. 592
• Main Authors: Scotti, Luciana, Mendonca Junior, Francisco J B, Ishiki, Hamilton M, Ribeiro, Frederico F, Singla, Rajeev K, Barbosa Filho, Jose M, Da Silva, Marcelo S, Scotti, Marcus T
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01-04-2017
• Subjects: Animals; Computational Biology - methods; Computer-Aided Design; Drug Design; Humans; Models, Theoretical; Molecular Docking Simulation; Polypharmacology; CADD; docking; receptor; polypharmacology; diseases; multi-target drugs; network
• ISSN: 1873-5592
• DOI: 10.2174/1389450116666150825111818

The most basic principle of drug action is found in the lock and key model, where the highest possible affinity for a target that also avoids side effects is desired. For many years this was understood as being "one drug, for one target, for one disease", however researchers began to observe that certain diseases are best treated with multi-target drugs. In recent years, studies have sought out polypharmacological compounds acting on multiple targets against complex (multifactorial) diseases, such as cancer, neurodegenerative disease, and certain infections. One of the computational tools used in research for multifunctional drugs is Molecular Docking. Through this methodology of Computer-Aided Drug Design, we observe complexes formed between ligands and interesting targets (often many), for a particular disease. This review reports on docking studies as used in investigations of new multi-target compounds; it also shows the various ways that such studies are used in the search for multifunctional compounds.